The myb and myc nuclear oncogenes as transcriptional activators
- 1 June 1990
- journal article
- review article
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 2 (3) , 502-508
- https://doi.org/10.1016/0955-0674(90)90134-z
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activationNature, 1990
- The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1.Molecular and Cellular Biology, 1990
- The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 geneCell, 1989
- BAS1 Has a Myb Motif and Activates HIS4 Transcription Only in Combination with BAS2Science, 1989
- Activation of transcription by v-myb: evidence for two different mechanisms.Genes & Development, 1989
- Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-mybCell, 1989
- A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteinsCell, 1989
- Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.Molecular and Cellular Biology, 1989
- Viral myb oncogene encodes a sequence-specific DNA-binding activityNature, 1988
- The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding ProteinsScience, 1988